高级搜索

miR-325-3p靶向CLDN1基因调控胃癌上皮间质转化和侵袭转移

杜记涛, 曹建, 赵稳, 万相斌, 李智

杜记涛, 曹建, 赵稳, 万相斌, 李智. miR-325-3p靶向CLDN1基因调控胃癌上皮间质转化和侵袭转移[J]. 肿瘤防治研究, 2021, 48(7): 686-693. DOI: 10.3971/j.issn.1000-8578.2021.20.1200
引用本文: 杜记涛, 曹建, 赵稳, 万相斌, 李智. miR-325-3p靶向CLDN1基因调控胃癌上皮间质转化和侵袭转移[J]. 肿瘤防治研究, 2021, 48(7): 686-693. DOI: 10.3971/j.issn.1000-8578.2021.20.1200
DU Jitao, CAO Jian, ZHAO Wen, WAN Xiangbin, LI Zhi. miR-325-3p Regulates Epithelial-mesenchymal Transition, Invasion and Metastasis of Gastric Cancer via Targeting CLDN1 Gene[J]. Cancer Research on Prevention and Treatment, 2021, 48(7): 686-693. DOI: 10.3971/j.issn.1000-8578.2021.20.1200
Citation: DU Jitao, CAO Jian, ZHAO Wen, WAN Xiangbin, LI Zhi. miR-325-3p Regulates Epithelial-mesenchymal Transition, Invasion and Metastasis of Gastric Cancer via Targeting CLDN1 Gene[J]. Cancer Research on Prevention and Treatment, 2021, 48(7): 686-693. DOI: 10.3971/j.issn.1000-8578.2021.20.1200

miR-325-3p靶向CLDN1基因调控胃癌上皮间质转化和侵袭转移

基金项目: 

河南省科技攻关项目 162102310317

详细信息
    作者简介:

    杜记涛(1984-),男,硕士,主治医师,主要从事胃肠道肿瘤相关研究

    通信作者:

    李智(1972-),男,博士,主任医师,主要从事胃肠道肿瘤相关研究,E-mail: 275829123@qq.com

  • 中图分类号: R735.2

miR-325-3p Regulates Epithelial-mesenchymal Transition, Invasion and Metastasis of Gastric Cancer via Targeting CLDN1 Gene

Funding: 

Henan Provincial Department of Science and Technology Research Project 162102310317

More Information
  • 摘要:
    目的 

    探讨miR-325-3p靶向CLDN1基因对胃癌上皮间质转化和侵袭转移的影响。

    方法 

    选取人胃黏膜上皮细胞株GES-1以及人胃癌细胞株HGC27、SGC-7901、MKN-45和MGC-803,并检测细胞中miR-325-3p和CLDN1的表达。双荧光素酶报告实验验证miR-325-3p和CLDN1的靶向关系,干预胃癌细胞中miR-325-3p和CLDN1的表达,qRT-PCR和Western blot检测细胞中N-cadherin、Vimentin和MMP2的表达,CCK-8检测细胞增殖活力,Transwell和流式细胞仪分别检测细胞侵袭和凋亡能力。

    结果 

    相对于GES-1细胞,MGC-803细胞中miR-325-3p表达降低而CLDN1表达增高(均P < 0.05),双荧光素酶报告实验证实CLDN1为miR-325-3p的靶基因。过表达miR-325-3p能够抑制胃癌细胞的增殖、侵袭和上皮间质转化,促进胃癌细胞凋亡,抑制miR-325-3p则能够促进胃癌细胞的增殖、侵袭和上皮间质转化,抑制胃癌细胞凋亡(均P < 0.05)。而过表达CLDN1则能够逆转miR-325-3p过表达对胃癌细胞生物学行为的影响。

    结论 

    miR-325-3p能够靶向抑制CLDN1进而抑制胃癌细胞的侵袭转移和上皮间质转化,促进胃癌细胞凋亡,miR-325-3p有望成为治疗胃癌的新靶点。

     

    Abstract:
    Objective 

    To investigate the effects of miR-325-3p on the EMT, invasion and metastasis of gastric cancer cells by targeting CLDN1 gene.

    Methods 

    We selected human gastric epithelial cell lines GES-1 and gastric cancer cell lines HGC27, SGC-7901, MKN-45 and MGC-803, and detected the expression of miR-325-3p and CLDN1. The targeting relation between miR-325-3p and CLDN1 were verified by dual luciferase report experiments, and the expression of miR-325-3p and CLDN1 in gastric cancer cells were intervened. qRT-PCR and Western blot were adopted to detect N-cadherin, vimentin and MMP2 expression in cells. CCK-8 assay, Transwell assay, flow cytometry were utilized to detect cell proliferation activity, invasion and apoptosis, respectively.

    Results 

    Compared with GES-1 cells, miR-325-3p expression was decreased while CLDN1 expression was increased in MGC-803 cells (P < 0.05). CLDN1 was a target gene of miR-325-3p. Overexpression of miR-325-3p could inhibit the proliferation, invasion and EMT of gastric cancer cells, while promote the apoptosis of gastric cancer cells. However, the inhibition of miR-325-3p had the opposite effect (P < 0.05). The overexpression of CLDN1 could reverse the effect of miR-325-3p overexpression on the biological behavior of gastric cancer cells.

    Conclusion 

    miR-325-3p can suppress CLDN1, inhibit the invasion, metastasis and EMT while promote the apoptosis of gastric cancer cells. miR-325-3p is expected to be a new target in gastric cancer treatment.

     

  • Competing interests: The authors declare that they have no competing interests.
    作者贡献:
    杜记涛:实验方案设计、文章撰写和修改
    曹建、赵稳:实验实施、数据统计
    万相斌:文章撰写、数据核查
    李智:实验方案设计、文章审核和修改
  • 图  1   不同癌组织和细胞中miR-325-3p和CLDN1的表达

    Figure  1   Expression of miR-325-3p and CLDN1 in different cancer tissues and cell lines

    图  2   miR-325-3p与CLDN1的靶向关系验证

    Figure  2   Validation of targeting relation between miR-325-3p and CLDN1

    图  3   过表达miR-325-3p后各组细胞凋亡(A, B)和增殖(C)能力检测结果

    Figure  3   Cell apoptosis(A, B) and proliferation(C) of each group after miR-325-3p was overexpressed

    图  4   过表达miR-325-3p后各组细胞侵袭能力(A)和EMT相关因子mRNA(B)及蛋白(C)的表达

    Figure  4   Cell invasion(A) and EMT-related factors mRNA(B) and protein(C) expression in each group after miR-325-3p was overexpressed

    图  5   过表达CLDN1后各组细胞增殖(A, B)和凋亡(C)能力检测结果

    Figure  5   Cell proliferation(A, B) and apoptosis(C) of each group after CLDN1 was overexpressed

    图  6   过表达CLDN1后各组细胞侵袭能力(A)和EMT相关因子mRNA(B)及蛋白(C)的表达

    Figure  6   Cell invasion(A) and EMT-related factors mRNA(B) and protein(C) expression in each group after CLDN1 was overexpressed

    表  1   qRT-PCR引物

    Table  1   qRT-PCR primer sequences

    下载: 导出CSV
  • [1]

    Zou J, Qin W, Yang L, et al. Genetic alterations and expression characteristics of ARID1A impact tumor immune contexture and survival in early-onset gastric cancer[J]. Am J Cancer Res, 2020, 10(11): 3947-3972. http://www.researchgate.net/publication/348247967_Genetic_alterations_and_expression_characteristics_of_ARID1A_impact_tumor_immune_contexture_and_survival_in_early-onset_gastric_cancer

    [2]

    Zhang TQ, Zhang KP, Ji KY, et al. microRNA-365 inhibits YAP through TLR4-mediated IRF3 phosphorylation and thereby alleviates gastric precancerous lesions[J]. Cancer Cell Int, 2020, 20(1): 549. doi: 10.1186/s12935-020-01578-0

    [3]

    Yao SH, Zhao TJ, Jin H. Expression of MicroRNA-325-3p and its potential functions by targeting HMGB1 in non-small cell lung cancer[J]. Biomed Pharmacother, 2015, 70: 72-79. doi: 10.1016/j.biopha.2015.01.013

    [4]

    Li R, Zheng JZ, Huang X. Suppression of HAX-1 induced by miR-325 resensitizes bladder cancer cells to cisplatin-induced apoptosis[J]. Eur Rev Med Pharmacol Sci, 2020, 24(18): 9303-9314. http://www.researchgate.net/publication/345939462_Suppression_of_HAX-1_induced_by_miR-325_resensitizes_bladder_cancer_cells_to_cisplatin-induced_apoptosis

    [5]

    Sun TH, Li K, Zhu K, et al. SNHG6 Interacted with miR-325-3p to Regulate Cisplatin Resistance of Gastric Cancer by Targeting GITR[J]. Onco Targets Ther, 2020, 13: 12181-12193. doi: 10.2147/OTT.S262896

    [6]

    Akizuki R, Maruhashi R, Eguchi H, et al. Decrease in paracellular permeability and chemosensitivity to doxorubicin by claudin-1 in spheroid culture models of human lung adenocarcinoma A549 cells[J]. Biochim Biophys Acta Mol Cell Res, 2018, 1865(5): 769-780. doi: 10.1016/j.bbamcr.2018.03.001

    [7]

    Wu JE, Wu YY, Tung CH, et al. DNA methylation maintains the CLDN1-EPHB6-SLUG axis to enhance chemotherapeutic efficacy and inhibit lung cancer progression[J]. Theranostics, 2020, 10(19): 8903-8923. doi: 10.7150/thno.45785

    [8]

    Ríos-Romero M, Cedro-Tanda A, Peña-Luna M, et al. FAM83H-AS1 is a potential modulator of cancer driver genes across different tumors and a prognostic marker for ER/PR + BRCA patients[J]. Sci Rep, 2020, 10(1): 14145. doi: 10.1038/s41598-020-71062-2

    [9]

    Eftang LL, Esbensen Y, Tannæs TM, et al. Up-regulation of CLDN1 in gastric cancer is correlated with reduced survival[J]. BMC Cancer, 2013, 13: 586. doi: 10.1186/1471-2407-13-586

    [10] 陈学书, 袁航, 龙妮娅, 等. 胃癌组织中肿瘤相关成纤维细胞与正常成纤维细胞之间转录组学研究及验证[J]. 中国生物化学与分子生物学报, 2018, 34(4): 427-433. https://www.cnki.com.cn/Article/CJFDTOTAL-SWHZ201804010.htm

    Chen XS, Yuan H, Long NY, et al. Transcriptomics study for differentially expressed genes between CAFs and NFs in gastric cancer[J]. Zhongguo Sheng Wu Hua Xue Yu Fen Zi Sheng Wu Xue Bao, 2018, 34(4): 427-433. https://www.cnki.com.cn/Article/CJFDTOTAL-SWHZ201804010.htm

    [11] 张大伟, 吴剑, 任德莲, 等. CLDN1在食管鳞癌中的表达及其分布异常在食管癌发生中的作用[J]. 四川大学学报(医学版), 2017, 48(6): 850-856. https://www.cnki.com.cn/Article/CJFDTOTAL-HXYK201706009.htm

    Zhang DW, Wu J, Ren DL, et al. Expression of CLDN1 and Its Nuclear Distribution in Esophageal Squamous Carcinoma[J]. Sichuan Da Xue Xue Bao(Yi Xue Ban), 2017, 48(6): 850-856. https://www.cnki.com.cn/Article/CJFDTOTAL-HXYK201706009.htm

    [12]

    Blanchard AA, Zelinski T, Xie J, et al. Identification of Claudin 1 Transcript Variants in Human Invasive Breast Cancer[J]. PLoS One, 2016, 11(9): e0163387. doi: 10.1371/journal.pone.0163387

    [13]

    Dey S, Liu S, Factora TD, et al. Global targetome analysis reveals critical role of miR-29a in pancreatic stellate cell mediated regulation of PDAC tumor microenvironment[J]. BMC Cancer, 2020, 20(1): 651. doi: 10.1186/s12885-020-07135-2

    [14] 高红艳, 郭洁, 吴方雄, 等. miRNA-451通过MRP靶向调控胃癌细胞对5-Fu耐药性的机制研究[J]. 肿瘤防治研究, 2019, 46(12): 1073-1077. doi: 10.3971/j.issn.1000-8578.2019.19.0618

    Gao HY, Guo J, Wu FX, et al. Mechanism of miRNA-451 Regulating Resistance of Gastric Cancer Cells to 5-Fu Through MRP[J]. Zhong Liu Fang Zhi Yan Jiu, 2019, 46(12): 1073-1077. doi: 10.3971/j.issn.1000-8578.2019.19.0618

    [15] 骆晓琴, 何娴, 刘星. 长链非编码RNA MALAT1对鼻咽癌转移和上皮间质转化的影响[J]. 中国临床药理学杂志, 2020, 36(11): 1524-1527. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ202011033.htm

    Luo XQ, He X, Liu X. Effects of long non-coding RNA MALAT1 on metastasis and epithelial mesenchymal transformation of nasopharyngeal carcinoma[J]. Zhongguo Lin Chuang Yao Li Xue Za Zhi, 2020, 36(11): 1524-1527. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ202011033.htm

    [16] 歧红阳, 王云溪, 肖占宇, 等. hsa-miR-448过表达下调HIF-1α对结肠癌细胞SW480作用及机制研究[J]. 中国免疫学杂志, 2019, 35(19): 2350-2356. doi: 10.3969/j.issn.1000-484X.2019.19.009

    Qi HY, Wang YX, Xiao ZY, et al. Effect and mechanism of overexpression of hsa-miR-448 by down-regulating HIF-1α on colon cancer cell line SW480[J]. Zhongguo Mian Yi Xue Za Zhi, 2019, 35(19): 2350-2356. doi: 10.3969/j.issn.1000-484X.2019.19.009

    [17]

    Yi Y, Zeng S, Wang Z, et al. Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling[J]. Biochim Biophys Acta Mol Basis Dis, 2018, 1864(3): 793-803. doi: 10.1016/j.bbadis.2017.12.021

    [18] 王丹凤, 郭晓娜, 张亚林, 等. 西达苯胺抑制人胃癌SGC-7901细胞侵袭机制探讨[J]. 中华肿瘤防治杂志, 2019, 26(15): 1072-1078. https://www.cnki.com.cn/Article/CJFDTOTAL-QLZL201915003.htm

    Wang DF, Guo XN, Zhang YL, et al. Chidamide inhibits invasion of human gastric carcinoma SGC-7901 cells via up-regulating SFRP2[J]. Zhonghua Zhong Liu Fang Zhi Za Zhi, 2019, 26(15): 1072-1078. https://www.cnki.com.cn/Article/CJFDTOTAL-QLZL201915003.htm

    [19]

    Jin H, ZhaoY, Zhang S, et al. Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of epithelial-mesenchymal transition[J]. Mol Med Rep, 2018, 17(5): 7274-7280.

    [20]

    Wu H, Li S. Long non-coding RNA MT1JP exerts anti-cancer effects in breast cancer cells by regulating miR-92-3p[J]. Gen Physiol Biophys, 2020, 39(1): 59-67. doi: 10.4149/gpb_2019039

    [21]

    Chen L, Lu Z, Yang Y, et al. Effects of purified Omphalia lapidescens protein on metastasis, cell cycle, apoptosis and the JAK-STAT signaling pathway in SGC-7901 human gastric cells[J]. Oncol Lett, 2018, 15(4): 4161-4170. http://www.ingentaconnect.com/content/sp/ol/2018/00000015/00000004/art00016

  • 期刊类型引用(2)

    1. 王海宏,宋玉,贺凡,杨兵,唐东昕,吴文宇. 基于伏邪理论探讨循环肿瘤细胞与结直肠癌复发转移的相关性. 中医杂志. 2024(19): 1983-1987 . 百度学术
    2. 阙祖俊,田建辉. 根除休眠播散肿瘤细胞防止肿瘤转移的潜在治疗药物的研究进展. 中国肿瘤生物治疗杂志. 2024(11): 1146-1151 . 百度学术

    其他类型引用(0)

图(6)  /  表(1)
计量
  • 文章访问数:  2215
  • HTML全文浏览量:  602
  • PDF下载量:  671
  • 被引次数: 2
出版历程
  • 收稿日期:  2020-10-14
  • 修回日期:  2021-03-20
  • 网络出版日期:  2024-01-12
  • 刊出日期:  2021-07-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭